Step therapy policies can play an important role in determining which treatments patients can access—and when. In oncology, where treatment decisions can be particularly complex and time-sensitive, understanding how these policies work is essential for life sciences professionals.
What Is Step Therapy?
Step therapy, sometimes called a “fail first” policy, is a form of utilization management that may require a patient to try one treatment before coverage is approved for another.
These policies are designed to help manage appropriate treatment use and healthcare costs, but their impact can look different depending on the stakeholder involved.
CMR Institute’s new Oncology Utilization Management: Implementing Step Edits, or “Fail First” Policies SoundBite provides a quick introduction to how step therapy works and what it means across the healthcare ecosystem.
In this SoundBite, learners will be able to:
- Explain what step therapy is and how it works as a form of prior authorization.
- Identify how step therapy affects physicians, patients, payers, and manufacturers differently.
Why Understanding Step Therapy Matters
For life sciences professionals, understanding step therapy provides important context for the access challenges that can influence treatment decisions. It can acquaint teams with the perspectives of physicians and patients navigating coverage requirements, the considerations facing payers, and the implications for manufacturers working to support access to therapies
Build Market Access Knowledge in Minutes
CMR Institute SoundBites make it easier to build knowledge around important and evolving healthcare topics through short, focused learning.
Add the Oncology Utilization Management: Implementing Step Edits, or “Fail First” Policies SoundBite to your training program and help your teams better understand how utilization management can shape access to oncology treatments.
